Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC

NCT07365592 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Anti-PD-1 monoclonal antibody
DRUG: Sitagliptin (DPP4 inhibitor)

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University